DY Mason
-
- Lymphoma Diagnosis and Treatment 10
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Immunology top 5%
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 2
- Dermatology top 2%
-
- Acute Lymphoblastic Leukemia research 3
-
- Peptidase Inhibition and Analysis 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- K C GatterBrunangelo FaliniGeorges DelsolHilmar LemkeK. LennertMargaret T. JonesJohannes GerdesGorm Pallesen
- Partner nations
- United KingdomItalyGermany
In The Last Decade
DY Mason
13 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Pathology and Forensic Medicine 770
- Genetics 266
- Immunology 438
- Hematology 231
- Dermatology 178
Countries citing papers authored by DY Mason
This map shows the geographic impact of DY Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DY Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DY Mason more than expected).
Fields of papers citing papers by DY Mason
This network shows the impact of papers produced by DY Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DY Mason. The network helps show where DY Mason may publish in the future.
Co-authorship network
The 25 scholars most cited alongside DY Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 33 | |
| 2 | ALK-1 antibody staining pattern in anaplastic large cell lymphoma (ALCL) and ALCL-Hodgkin's like | 1997 | 2 |
| 3 | 1995 | 106 | |
| 4 | 1995 | 141 | |
| 5 | 1993 | 37 | |
| 6 | 1993 | 44 | |
| 7 | 1992 | 81 | |
| 8 | 1990 | 122 | |
| 9 | 1988 | 7 | |
| 10 | 1988 | 181 | |
| 11 | 1987 | 7 | |
| 12 | The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsbreakdown → | 1985 | 568 |
| 13 | 1981 | 12 |
About DY Mason
DY Mason is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Peptidase Inhibition and Analysis (2 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (770 citations), Genetics (266 citations) and Immunology (438 citations). DY Mason has collaborated with scholars based in United Kingdom, Italy and Germany. Frequent co-authors include K C Gatter, Brunangelo Falini, Georges Delsol, Hilmar Lemke, K. Lennert, Margaret T. Jones, Johannes Gerdes, Gorm Pallesen, Roland Schwarting and H Stein. Their work appears in journals such as Blood, Journal of Clinical Pathology, British Journal of Cancer, Laboratory Investigation and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.